Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 137

    1.

    HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.

    Valenti L, Girelli D, Valenti GF, Castagna A, Como G, Campostrini N, Rametta R, Dongiovanni P, Messa P, Fargion S.

    Clin J Am Soc Nephrol. 2009 Aug;4(8):1331-7. Epub 2009 Jun 18.PMID: 19541813 [PubMed - indexed for MEDLINE]Related articles

    2.

    The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

    Valenti L, Fracanzani AL, Fargion S.

    Semin Immunopathol. 2009 Sep;31(3):359-69. Epub 2009 May 14.PMID: 19440711 [PubMed - in process]Related articles

    3.

    Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis.

    Carulli L, Canedi I, Rondinella S, Lombardini S, Ganazzi D, Fargion S, De Palma M, Lonardo A, Ricchi M, Bertolotti M, Carulli N, Loria P.

    Dig Liver Dis. 2009 Nov;41(11):823-8. Epub 2009 Apr 28.PMID: 19403348 [PubMed - in process]Related articles

    4.

    Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations?

    Valenti L, Fracanzani AL, Dongiovanni P, Vezzoli P, Fargion S.

    Intern Emerg Med. 2009 Feb;4(1):91-2. Epub 2008 Nov 4. No abstract available. PMID: 18982250 [PubMed - indexed for MEDLINE]Related articles

    5.

    Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

    Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.

    Hepatology. 2008 Sep;48(3):792-8.PMID: 18752331 [PubMed - indexed for MEDLINE]Related articles

    6.

    Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.

    Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L.

    Osteoporos Int. 2009 Apr;20(4):549-55. Epub 2008 Jul 26.PMID: 18661088 [PubMed - in process]Related articles

    7.

    HFE mutations in nonalcoholic fatty liver disease.

    Valenti L, Dongiovanni P, Fracanzani AL, Fargion S.

    Hepatology. 2008 May;47(5):1794-5; author reply 1795-6. No abstract available. PMID: 18438784 [PubMed - indexed for MEDLINE]Related articles

    8.

    Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels: suggestions for diagnostic procedures and monitoring.

    Morisco F, Pagliaro L, Caporaso N, Bianco E, Sagliocca L, Fargion S, Smedile A, Salvagnini M, Mele A; University of Naples Federico II, italy.

    Dig Liver Dis. 2008 Jul;40(7):585-98. Epub 2008 Apr 18.PMID: 18395501 [PubMed - indexed for MEDLINE]Related articles

    9.

    Ferroportin-1 in the recurrence of hepatic iron overload after liver transplantation.

    Valenti L, Guido M, Dongiovanni P, Cremonesi L, Fracanzani AL, Fargion S.

    Dig Liver Dis. 2009 Jul;41(7):e17-20. Epub 2008 Mar 11.PMID: 18337195 [PubMed - indexed for MEDLINE]Related articles

    10.

    Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.

    Valenti L, Rametta R, Dongiovanni P, Maggioni M, Fracanzani AL, Zappa M, Lattuada E, Roviaro G, Fargion S.

    Diabetes. 2008 May;57(5):1355-62. Epub 2008 Mar 3.PMID: 18316359 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations: response to Equitani et al.

    Valenti L, Dongiovanni P, Fracanzani AL, Fargion S.

    Diabetes Care. 2008 Mar;31(3):e18; author reply e19. No abstract available. PMID: 18308681 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver.

    Dongiovanni P, Valenti L, Ludovica Fracanzani A, Gatti S, Cairo G, Fargion S.

    Am J Pathol. 2008 Mar;172(3):738-47. Epub 2008 Feb 2.PMID: 18245813 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.

    Valenti L, Dongiovanni P, Fargion S, Fracanzani AL.

    J Hepatol. 2008 Mar;48(3):513-4; author reply 514-5. Epub 2007 Dec 31. No abstract available. PMID: 18194822 [PubMed - indexed for MEDLINE]Related articles

    14.

    Carotid artery intima-media thickness in nonalcoholic fatty liver disease.

    Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, Santorelli G, Valenti L, Maraschi A, Catapano A, Fargion S.

    Am J Med. 2008 Jan;121(1):72-8.PMID: 18187076 [PubMed - indexed for MEDLINE]Related articles

    15.

    The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload.

    Valenti L, Fracanzani AL, Rossi V, Rampini C, Pulixi E, Varenna M, Fargion S, Sinigaglia L.

    J Rheumatol. 2008 Jan;35(1):153-8.PMID: 18061976 [PubMed - indexed for MEDLINE]Related articles

    16.

    HFE genotype influences erythropoiesis support requirement in hemodialysis patients: a prospective study.

    Valenti L, Valenti G, Como G, Santorelli G, Dongiovanni P, Rametta R, Fracanzani AL, Tavazzi D, Messa PG, Fargion S.

    Am J Nephrol. 2008;28(2):311-6. Epub 2007 Nov 16.PMID: 18025780 [PubMed - indexed for MEDLINE]Related articles

    17.

    Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.

    Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL.

    Haematologica. 2007 Aug;92(8):1037-42. Epub 2007 Jul 20.PMID: 17640859 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

    Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S.

    Am J Gastroenterol. 2007 Jun;102(6):1251-8. Epub 2007 Mar 27.PMID: 17391316 [PubMed - indexed for MEDLINE]Related articles

    19.

    Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy.

    Saitta C, Pontisso P, Brunetto MR, Fargion S, Gaeta GB, Niro GA, Picciotto A, Smedile A, Squadrito G, Raimondo G.

    Antivir Ther. 2006;11(7):931-4.PMID: 17302256 [PubMed - indexed for MEDLINE]Related articles

    20.

    HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients.

    Valenti L, Valenti G, Como G, Burdick L, Santorelli G, Dongiovanni P, Rametta R, Bamonti F, Novembrino C, Fracanzani AL, Messa PG, Fargion S.

    Am J Nephrol. 2007;27(1):101-7. Epub 2007 Feb 13.PMID: 17299255 [PubMed - indexed for MEDLINE]Related articles

    21.

    Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study.

    Benetti G, Borzio M, Ramella G, Bellati G, Fargion S, Colombo A, Croce G, Iamoletti C, Balzola F, Rizzetto M; GEL (Gruppo Epatologico Lombardo).

    Intern Emerg Med. 2006;1(2):113-8.PMID: 17111783 [PubMed - indexed for MEDLINE]Related articles

    22.

    Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.

    Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S.

    Hepatology. 2006 Oct;44(4):857-64.PMID: 17006922 [PubMed - indexed for MEDLINE]Related articles

    23.

    Triple antiviral therapy in HCV positive patients who failed prior combination therapy.

    Fargion S, Borzio M, Maraschi A, Cargnel A; Gruppo Epatologico Lombardo.

    World J Gastroenterol. 2006 Sep 7;12(33):5293-300.PMID: 16981257 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Iron and insulin resistance.

    Fargion S, Dongiovanni P, Guzzo A, Colombo S, Valenti L, Fracanzani AL.

    Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:61-3.PMID: 16225476 [PubMed - indexed for MEDLINE]Related articles

    25.

    TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

    Valenti L, Pulixi E, Fracanzani AL, Dongiovanni P, Maggioni M, Orsatti A, Gianni C, Fargion S.

    J Hepatol. 2005 Dec;43(6):944-50. Epub 2005 Jul 5.PMID: 16143422 [PubMed - indexed for MEDLINE]Related articles

    26.

    Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

    Fracanzani AL, Fargion S, Stazi MA, Valenti L, Amoroso P, Cariani E, Sangiovanni A, Tommasini M, Rossini A, Bertelli C, Fatta E, Patriarca V, Brescianini S, Stroffolini T.

    Blood Cells Mol Dis. 2005 Jul-Aug;35(1):27-32.PMID: 15894495 [PubMed - indexed for MEDLINE]Related articles

    27.

    Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease.

    Ma Y, Meregalli M, Hodges S, Davies N, Bogdanos DP, Fargion S, Fiorelli G, Vergani D.

    Int J Immunopathol Pharmacol. 2005 Jan-Mar;18(1):173-82.PMID: 15698522 [PubMed - indexed for MEDLINE]Related articles

    28.

    The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis.

    Valenti L, Conte D, Piperno A, Dongiovanni P, Fracanzani AL, Fraquelli M, Vergani A, Gianni C, Carmagnola L, Fargion S.

    J Med Genet. 2004 Dec;41(12):946-50.PMID: 15591282 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report.

    Salvi M, Vannucchi G, Sbrozzi F, Del Castello AB, Carnevali A, Fargion S, Beck-Peccoz P.

    Thyroid. 2004 Aug;14(8):631-4.PMID: 15320978 [PubMed - indexed for MEDLINE]Related articles

    30.

    Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients.

    Valenti L, De Feo T, Fracanzani AL, Fatta E, Salvagnini M, Aricò S, Rossi G, Fiorelli G, Fargion S.

    Alcohol Alcohol. 2004 Jul-Aug;39(4):276-80.PMID: 15208156 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Searching for coeliac disease in patients with non-alcoholic fatty liver disease.

    Bardella MT, Valenti L, Pagliari C, Peracchi M, Farè M, Fracanzani AL, Fargion S.

    Dig Liver Dis. 2004 May;36(5):333-6.PMID: 15191202 [PubMed - indexed for MEDLINE]Related articles

    32.

    Treatment choices for people infected with HCV.

    Fargion S, Fracanzani AL, Valenti L.

    J Antimicrob Chemother. 2004 May;53(5):708-12. Epub 2004 Apr 8. Review.PMID: 15073158 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    TNFalpha promoter polymorphisms.

    Fargion S, Valenti L, Dongiovanni P, Fracanzani AL.

    Methods Mol Med. 2004;98:47-58.PMID: 15064432 [PubMed - indexed for MEDLINE]Related articles

    34.

    Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.

    Velati C, Marlianici E, Rigamonti D, Barillari G, Chiavilli F, Fugiani P, Garozzo G, Lancieri M, Rinaldi S, Testa D, Sampietro M, Tavazzi D, Delbini P, Fargion S, Fiorelli G.

    Hematol J. 2003;4(6):436-40.PMID: 14671617 [PubMed - indexed for MEDLINE]Related articles

    35.

    What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?

    Zavaroni I, Numeroso F, Dongiovanni P, Ardigò D, Valenti L, Fracanzani A, Valtuena S, Delsignore R, Fargion S, Reaven GM.

    Metabolism. 2003 Dec;52(12):1593-6.PMID: 14669161 [PubMed - indexed for MEDLINE]Related articles

    36.

    TNFalpha promoter polymorphisms in Italian patients with porphyria cutanea tarda.

    Dongiovanni P, Valenti L, Fracanzani AL, Cappellini MD, Fargion S, Taioli E.

    Dig Liver Dis. 2003 Aug;35(8):596-7. No abstract available. PMID: 14567466 [PubMed - indexed for MEDLINE]Related articles

    37.

    Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning.

    Cremonesi L, Foglieni B, Fermo I, Cozzi A, Paroni R, Ruggeri G, Belloli S, Levi S, Fargion S, Ferrari M, Arosio P.

    Haematologica. 2003 Oct;88(10):1110-6.PMID: 14555306 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Prevalence of hepatitis C virus infection in porphyria cutanea tarda.

    Fargion S, Fracanzani AL.

    J Hepatol. 2003 Oct;39(4):635-8. Review. No abstract available. PMID: 12971977 [PubMed - indexed for MEDLINE]Related articles

    39.

    Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.

    Borzio M, Fargion S, Borzio F, Fracanzani AL, Croce AM, Stroffolini T, Oldani S, Cotichini R, Roncalli M.

    J Hepatol. 2003 Aug;39(2):208-14.PMID: 12873817 [PubMed - indexed for MEDLINE]Related articles

    40.

    Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

    Valenti L, Dongiovanni P, Fracanzani AL, Santorelli G, Fatta E, Bertelli C, Taioli E, Fiorelli G, Fargion S.

    Dig Liver Dis. 2003 Mar;35(3):172-8.PMID: 12779071 [PubMed - indexed for MEDLINE]Related articles

    41.

    Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon.

    Fargion S, Bruno S, Borzio M, Battezzati PM, Bissoli F, Ceriani R, Orlandi A, Maraschi A, Chiesa A, Morini L, Fracanzani AL, Crosignani A, Fiorelli G, Podda M.

    J Hepatol. 2003 Apr;38(4):499-505.PMID: 12663243 [PubMed - indexed for MEDLINE]Related articles

    42.

    Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance.

    Valenti L, Fracanzani AL, Fargion S.

    Gastroenterology. 2003 Mar;124(3):866; author reply 866-7. No abstract available. PMID: 12612935 [PubMed - indexed for MEDLINE]Related articles

    43.

    Peripheral lymphocytes and intracellular cytokines in C282Y homozygous hemochromatosis patients.

    Fabio G, Zarantonello M, Mocellin C, Bonara P, Corengia C, Fargion S, Fiorelli G.

    J Hepatol. 2002 Dec;37(6):753-61.PMID: 12445415 [PubMed - indexed for MEDLINE]Related articles

    44.

    Natural history of juvenile haemochromatosis.

    De Gobbi M, Roetto A, Piperno A, Mariani R, Alberti F, Papanikolaou G, Politou M, Lockitch G, Girelli D, Fargion S, Cox TM, Gasparini P, Cazzola M, Camaschella C.

    Br J Haematol. 2002 Jun;117(4):973-9. Review.PMID: 12060140 [PubMed - indexed for MEDLINE]Related articles

    45.

    Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.

    Fargion S, Fracanzani AL, Rossini A, Borzio M, Riggio O, Belloni G, Bissoli F, Ceriani R, Ballarè M, Massari M, Trischitta C, Fiore P, Orlandi A, Morini L, Mattioli M, Oldani S, Cesana B, Fiorelli G.

    Am J Gastroenterol. 2002 May;97(5):1204-10.PMID: 12014729 [PubMed - indexed for MEDLINE]Related articles

    46.

    Levels of uroporphyrinogen decarboxylase (URO-D) in erythrocytes of Italian porphyria cutanea tarda patients.

    Tavazzi D, Martinez di Montemuros F, Fargion S, Fracanzani AL, Fiorelli G, Cappellini MD.

    Cell Mol Biol (Noisy-le-grand). 2002 Feb;48(1):27-32.PMID: 11929044 [PubMed - indexed for MEDLINE]Related articles

    47.

    Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis.

    Fiorelli G, De Feo TM, Duca L, Tavazzi D, Nava I, Fargion S, Cappellini MD.

    Eur J Clin Invest. 2002 Mar;32 Suppl 1:21-7.PMID: 11886428 [PubMed - indexed for MEDLINE]Related articles

    48.

    Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.

    Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, Fargion S.

    Gastroenterology. 2002 Feb;122(2):274-80.PMID: 11832442 [PubMed - indexed for MEDLINE]Related articles

    49.

    Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.

    Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, Maraschi A, Fiorelli G, Fargion S.

    Hepatology. 2001 Dec;34(6):1109-12.PMID: 11731999 [PubMed - indexed for MEDLINE]Related articles

    50.

    Non-transferrin-bound iron in alcohol abusers.

    De Feo TM, Fargion S, Duca L, Cesana BM, Boncinelli L, Lozza P, Cappellini MD, Fiorelli G.

    Alcohol Clin Exp Res. 2001 Oct;25(10):1494-9.PMID: 11696670 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...